ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 724462 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 724462; 2) Community: the network communities that were significantly associated with the response to NSC 724462; 3) Molecule: the relationships between components within communities and NSC 724462; 4) MDR: the compounds that were significantly associated with the NSC 724462.

NSC Compound Enrichment Correlation
NSC 695937 9-Acridinone, 1-[[[[(9-methoxy-5,11-dimethyl- 6H-pyrido[4,3-b]carbazol-1-yl)amino]-3-propyl(methyl) amino]-3-propyl]amino]-4-nitro-, dimethane sulfonate salt 0.0375780807984392 0.41147373
NSC 695939 Null 0.0375780807984392 0.41637229
NSC 711733 Null 0.0375780807984392 0.26688697
NSC 715775 11H-Indolo[1,2-b]indazolium, 11-[[4-(dimethylamino)phenyl]methylene]-6-methyl-, trifluoromethanesulfonate 0.0375780807984392 0.3546094
NSC 718727 5-[2-(2,5-Dimethoxyphenyl)ethynyl]-2-methoxyphenyl-N-hexylcarboxamide 0.0375780807984392 0.47046306
NSC 19441 FDA 0283 0.0399098711718627 0.020764065
NSC 670678 Glutamic acid, N-[4-[[[2-(ethoxycarbonyl)-3-quinoxalinyl] amino]phenyl]carbonyl]-, diethyl ester 0.0399098711718627 -0.34279497
NSC 680735 Null 0.0399098711718627 -0.12970676
NSC 698031 Null 0.0399098711718627 0.090649476
NSC 119875 Cisplatin 0.0430505868034758 -0.15988388
Total:112  Current:97    [First] [Prev] [Next] [Last]